2015
DOI: 10.2177/jsci.38.116
|View full text |Cite
|
Sign up to set email alerts
|

13-year history of scleroderma complicated by renal crisis and thrombotic microangiopathy treated with plasma exchange: A case report

Abstract: summaryA 77-year-old man with a 13-year history of systemic sclerosis (SSc) was admitted to our hospital with fever, appetite loss, and disorientation. The patient was well 2 days prior to the admission and had been taking a low dose of a steroid and vasodilators over the previous 10 years. In regular clinic visits, his blood pressure was normotensive and serum creatinine (Cr) was within the normal range. On admission, hypertension (blood pressure 214/105 mmHg), proteinuria, and hypercreatinemia (3.6 mg/dL) le… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1

Citation Types

0
1
0

Year Published

2018
2018
2020
2020

Publication Types

Select...
2

Relationship

0
2

Authors

Journals

citations
Cited by 2 publications
(1 citation statement)
references
References 1 publication
0
1
0
Order By: Relevance
“…After excluding the primary TMA and the possible secondary causes, the patient was evaluated for secondary TMA due to malignant hypertension after the rupturing of pheochromocytoma. Although plasma exchange is recommended for primary TMA, some studies show that plasma exchange therapy is beneficial in secondary TMA as well (19)(20)(21)(22). Since the platelet count of the patient increased above 200 (x10 3 /uL), along with a sufficient increase in hemoglobin level, plasma exchange therapy was discontinued.…”
Section: Discussionmentioning
confidence: 99%
“…After excluding the primary TMA and the possible secondary causes, the patient was evaluated for secondary TMA due to malignant hypertension after the rupturing of pheochromocytoma. Although plasma exchange is recommended for primary TMA, some studies show that plasma exchange therapy is beneficial in secondary TMA as well (19)(20)(21)(22). Since the platelet count of the patient increased above 200 (x10 3 /uL), along with a sufficient increase in hemoglobin level, plasma exchange therapy was discontinued.…”
Section: Discussionmentioning
confidence: 99%